# Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease

> **NCT06839820** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Akershus** · enrollment: 60 (estimated)

## Conditions studied

- Infliximab
- Infusion
- IBD (Inflammatory Bowel Disease)
- Patient Satisfaction

## Interventions

- **OTHER:** Infusion rate of infliximab

## Key facts

- **NCT ID:** NCT06839820
- **Lead sponsor:** University Hospital, Akershus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06839820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06839820, "Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06839820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*